Prestige Consumer Healthcare, Inc. (PBH)
47.53
-0.94
(-1.94%)
USD |
NYSE |
May 29, 16:00
47.54
+0.01
(+0.02%)
Pre-Market: 20:00
Prestige Consumer Healthcare EPS Diluted (Quarterly) : 1.131 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 8.255 |
| Amneal Pharmaceuticals, Inc. | 0.1893 |
| Crinetics Pharmaceuticals, Inc. | -1.228 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 53.93M |
| Revenue (Quarterly) | 281.62M |
| Total Expenses (Quarterly) | 227.69M |
| Enterprise Value | 3.233B |
| Gross Profit Margin (Quarterly) | 50.02% |
| Profit Margin (Quarterly) | 19.15% |
| Earnings Yield | 8.23% |
| Operating Earnings Yield | 13.36% |
| Normalized Earnings Yield | 8.229 |